Rebecca Mack

Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials

Thomas N. Kakuda, John D. Davis, Julia Hamlin et al. · Antimicrobial Agents and Chemotherapy · 2011 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics of Elvitegravir and Etravirine following Coadministration of Ritonavir-Boosted Elvitegravir and Etravirine

S. Ramanathan, Thomas N. Kakuda, Rebecca Mack et al. · Antiviral Therapy · 2008 · 35 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial

Calvin Cohen, Daniel S Berger, Gary Blick et al. · AIDS · 2009 · 27 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Ritonavir-Boosted Tipranavir or Darunavir on the Steady-State Pharmacokinetics of Elvitegravir

Anita Mathias, John E. Hinkle, Jeff Enejosa et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 25 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

Christoph Königs, Cornelia Feiterna‐Sperling, Susanna Esposito et al. · AIDS · 2011 · 15 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17